Paroxetine Treatment of Depression in Late Life
By Charles F. Reynolds III, MD
Paroxetine Treatment of Generalized Anxiety Disorder
By David V. Sheehan, MD, MBA, and C. Gloria Mao, PharmD
Paroxetine Treatment of Major Depressive Disorder
By Martin B. Keller, MD
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
By Karen Dineen Wagner, MD, PhD
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
By Kimberly A. Yonkers, MD
Paroxetine Use in Medically Ill Patients
By Steven Stout, MD, PhD, Wendy I. Somerset, MD, Andrew Miller, MD, and Dominique L. Musselman, MD, MS
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
By Robert M. Nevels, Samuel T. Gontkovsky, Bryman E. Williams
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
By Kasia Lobello, Sujana Reddy, Jeff Musgnung, Ronald Pedersen, Philip T. Ninan
Perfíl biográfico
Acerdándose a la salud mental fuera del consultorio: un perfil del Dr. Jaime Arroyo
Dr. Eduardo Gastelumendi D’Argent
Pharmacoeconomics of Cisplatin-Based Chemoradiation in Cervical Cancer: A Review
Peter G. Rose, MD, and Panos T. Lappas
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
By Lindsay DeVane, PharmD
By C. Lindsay DeVane, PharmD
Pharmacokinetics, Drug Interactions, and Tolerability of Valproate
Pharmacology and Therapeutic Use of Trastuzumab in Breast Cancer
By Imad Treish, PharmD, Rowena Schwartz, PharmD, BCOP, and Celeste Lindley, PharmD, BCPS, FASHP, FCCP
Pharmacology of Antineoplastic Agents in Older Cancer Patients
By J. Andrew Skirvin, PharmD, Sunitha Vemulapalli, MD, and Stuart M. Lichtman, MD
Pharmacology of Valproate
By Michael J. Owens, PhD, and Charles B. Nemeroff, MD, PhD
Pharmacotherapy of Neuropsychiatric Syndromes in Neurologic Disorders: Definitional and Regulatory Aspects
Jeffrey L. Cummings, MD and Dilip V. Jeste, MD
Pharmacy Practice
An Update on Cancer Chemoprevention
By Tammy Chernin, RPh
In Vitro Tests to Predict Human Tumor Sensitivity to Cytotoxic Agents
By Axel-R. Hanauske, MD, PhD
Monitoring Chemotherapy in an Aging Population
By Judith A. Smith, Pharm.D, BCOP
New Medicines in Development for Cancer
Pharmaceutical Research and Manufacturers of America (PhRMA)
Oral Chemotherapy for Colorectal Cancer: An Update
By Sunil Sharma, MD
The Contemporary Management of Colorectal Cancer
By David L. Grinblatt, MD, and Richard L. Schilsky, MD
The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer:
What Should Patients Be Told?
By Judith A. Smith, PharmD, BCOP
The Role of Chemoprotectants in Cancer Supportive Care
By Masha S. H. Lam, PharmD, and Robert J. Ignoffo, PharmD, FASHP